Table 1 Characteristics of study participants [Median (IQR)]
Group | N | Sex (n) | Age (years) | Duration of anti-TB treatment (months) | |
|---|---|---|---|---|---|
Male | Female | ||||
HC | 24 | 14 | 10 | 62 (48–70) | NA |
HW | 15 | 10 | 5 | 65 (56–70) | NA |
TB | 26 | 15 | 11 | 61 (44–67) | 4.4 (2.5–5.3) |
TB + HW | 17 | 9 | 8 | 60 (50–72) | 4.5 (3.0–5.4) |